Cargando…
Severe Oral Mucosal Ulceration Associated with Oral Bisphosphonate Use: The Importance of Imparting Proper Instructions on Medication Administration and Intake
Oral bisphosphonates are approved for the treatment of bone loss associated with several conditions including postmenopausal osteoporosis. Although generally well tolerated, adverse effects such as gastroesophageal reflux and oesophageal and peptic ulceration may occur. Oral mucositis and ulceration...
Autores principales: | Chandran, Manju, Zeng, Wanling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969094/ https://www.ncbi.nlm.nih.gov/pubmed/33777146 http://dx.doi.org/10.1155/2021/6620489 |
Ejemplares similares
-
Administration of bisphosphonate for hypercalcemia associated with oral cancer
por: Onizawa, Kojiro, et al.
Publicado: (2006) -
Eliminating the need for fasting with oral administration of bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2013) -
How Shall We Best Impart Dental Instruction to Patients?
por: Mills, George A.
Publicado: (1870) -
Oral microbiota dysbiosis accelerates the development and onset of mucositis and oral ulcers
por: Min, Ziyang, et al.
Publicado: (2023) -
Oral bisphosphonates and colorectal cancer
por: Vogtmann, Emily, et al.
Publicado: (2017)